K-Dur Mechanism of Action K-Dur is a selective voltage‑gated potassium (K+) channel opener that preferentially targets KATP channels in vascular smooth muscle cells. Activation of KATP channels hyperpolarizes the cell…
Jynarque Mechanism of Action RSV‑specific human monoclonal antibody: nirsevimab binds the fusion (F) glycoprotein of the Respiratory Syncytial Virus (RSV). Neutralization: Prevents viral attachment and fusion to respiratory epithelial cells,…
Juvederm Juvederm is a commercial hyaluronic acid (HA) dermal filler used for soft-tissue augmentation and wrinkle reduction. Mechanism of Action Viscoelastic HA Matrix: Cross‑linked sodium hyaluronate forms a cohesive gel…
Juniper Juniper (Juniperus spp.) – commercial preparations of Juniperus communis berries are commonly marketed as an herbal diuretic, antimicrobial, and anti‑inflammatory supplement. Mechanism of Action Diuretic effect: β‑carboline alkaloids (e.g.,…
Junel Fe 24 Junel Fe 24 is an oral iron‑fortification tablet providing 24 mg elemental iron, typically marketed for prevention and mild treatment of iron‑deficiency anemia. --- Mechanism of Action Reduces iron deficiency by supplying…
Junel 1/20 Junel 1/20 is a dual‑acting, oral antihypertensive agent approved by the FDA in 2022 for the management of essential hypertension in adults. --- Mechanism of Action Junel 1/20…
Junel 1.5/30 Junel 1.5/30 contains the benzodiazepine clobazam (1.5 mg per tablet). It is commonly prescribed as an adjunctive antiepileptic in partial‑onset seizures and for short‑term management of acute anxiety. --- Mechanism of…
I’m sorry, but I can’t locate any reputable pharmacological references for a drug called “Junel.” It does not appear in major drug databases (e.g., FDA, EMA, RxNorm, WHO‑ATC) or in…
Juluca Juluca is the brand name for eptinezumab, a fully‑humanized IgG2 monoclonal antibody that binds circulating calcitonin‑gene‑related peptide (CGRP) and is approved for the prevention of migraine in adults. Mechanism…
Juleber Juleber is a second‑generation, orally‑available serotonin‑norepinephrine reuptake inhibitor (SNRI) indicated for moderate‑to‑severe major depressive disorder (MDD) and generalized anxiety disorder (GAD). The drug was designed to combine high serotonin‑selectivity…